209 related articles for article (PubMed ID: 18192010)
21. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
Wierenga AT; Schuringa JJ; Eggen BJ; Kruijer W; Vellenga E
Leukemia; 2002 Apr; 16(4):675-82. PubMed ID: 11960349
[TBL] [Abstract][Full Text] [Related]
23. Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia.
Obermann EC; Arber C; Jotterand M; Tichelli A; Hirschmann P; Tzankov A
Ann Hematol; 2010 Jul; 89(7):663-9. PubMed ID: 20066533
[TBL] [Abstract][Full Text] [Related]
24. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.
Coppo P; Flamant S; De Mas V; Jarrier P; Guillier M; Bonnet ML; Lacout C; Guilhot F; Vainchenker W; Turhan AG
Br J Haematol; 2006 Jul; 134(2):171-9. PubMed ID: 16846476
[TBL] [Abstract][Full Text] [Related]
25. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
26. Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells.
Yan F; Shen N; Pang JX; Zhang YW; Rao EY; Bode AM; Al-Kali A; Zhang DE; Litzow MR; Li B; Liu SJ
Leukemia; 2017 Jun; 31(6):1434-1442. PubMed ID: 27885273
[TBL] [Abstract][Full Text] [Related]
27. Targeting novel signaling pathways for resistant acute myeloid leukemia.
Sakamoto KM; Grant S; Saleiro D; Crispino JD; Hijiya N; Giles F; Platanias L; Eklund EA
Mol Genet Metab; 2015 Mar; 114(3):397-402. PubMed ID: 25533111
[TBL] [Abstract][Full Text] [Related]
28. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
[TBL] [Abstract][Full Text] [Related]
29. The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine.
Miltiades P; Lamprianidou E; Vassilakopoulos TP; Papageorgiou SG; Galanopoulos AG; Kontos CK; Adamopoulos PG; Nakou E; Vakalopoulou S; Garypidou V; Papaioannou M; Hatjiharissi E; Papadaki HA; Spanoudakis E; Pappa V; Scorilas A; Tsatalas C; Kotsianidis I;
Clin Cancer Res; 2016 Apr; 22(8):1958-68. PubMed ID: 26700206
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.
Mohankumar KM; Perry JK; Kannan N; Kohno K; Gluckman PD; Emerald BS; Lobie PE
Endocrinology; 2008 May; 149(5):2219-29. PubMed ID: 18276758
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
Eriksson A; Lennartsson A; Lehmann S
Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
[TBL] [Abstract][Full Text] [Related]
32. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
33. A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts.
Xia Z; Salzler RR; Kunz DP; Baer MR; Kazim L; Baumann H; Wetzler M
Cancer Res; 2001 Feb; 61(4):1747-53. PubMed ID: 11245492
[TBL] [Abstract][Full Text] [Related]
34. Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.
Zhong Y; Feng J; Chen B; Cheng L; Li Y; Qian J; Ding J; Gao F; Xia G
Int J Lab Hematol; 2012 Aug; 34(4):383-9. PubMed ID: 22376160
[TBL] [Abstract][Full Text] [Related]
35. Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.
Reikvam H; Hoang TT; Bruserud Ø
Expert Rev Hematol; 2015 Jun; 8(3):315-27. PubMed ID: 25901742
[TBL] [Abstract][Full Text] [Related]
36. The increasing genomic complexity of acute myeloid leukemia.
Rowe JM
Best Pract Res Clin Haematol; 2014; 27(3-4):209-13. PubMed ID: 25455268
[TBL] [Abstract][Full Text] [Related]
37. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
[TBL] [Abstract][Full Text] [Related]
38. Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Stevens AM; Ruiz MJ; Gerbing RB; Alonzo TA; Gamis AS; Redell MS
Haematologica; 2015 Dec; 100(12):e496-500. PubMed ID: 26294728
[No Abstract] [Full Text] [Related]
39. The molecular pathogenesis of acute myeloid leukemia.
Steffen B; Müller-Tidow C; Schwäble J; Berdel WE; Serve H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic targeting and personalized approaches for AML.
Roboz GJ
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
